Cat.No. |
Chemical Name |
MolFormula |
HR341233 |
Acridin-2-amine |
C13H10N2 |
HR341230 |
Acridine-3,6-diamine hydrochloride |
C13H12ClN3 |
HR329274 |
Allyl (1H-benzo[d][1,2,3]triazol-1-yl) carbonate |
C10H9N3O3 |
HR324164 |
Androgen receptor-IN-3 |
C14H16N2O2S |
HR323724 |
Acenaphtho[1,2-d][1,3]thiazol-8-amine |
C13H8N2S |
HR323458 |
ARM1 |
C16H14N2S |
HR313903 |
Acetic acid;pyrimidin-5-ol |
C6H8N2O3 |
HR310945 |
ACT 080803 |
C16H13Br2N5O2 |
HR309539 |
AMPK activator 5 |
C25H31N3O4S |
HR306327 |
Argatroban-5 |
C25H35N7O7S |
HR298704 |
Aleglitazar (racemate) |
C24H23NO5S |
HR298090 |
Allyl 1-(4-amino-1,2,5-oxadiazol-3-yl)-5-methyl-1H-1,2,3-triazole-4-carboxylate |
C9H10N6O3 |
HR283392 |
Aureusimine B |
C14H16N2O |
HR283250 |
Azetidin-1-yl(5-chloropyrazin-2-yl)methanone |
C8H8ClN3O |
HR281786 |
Acid secretion-IN-1 |
C11H9NO2 |
HR281606 |
Apaziquone |
C15H16N2O4 |
HR280670 |
Antitubercular agent-3 |
C17H17N3O3 |
HR279767 |
Acetamide, 2-chloro-N-[3-cyano-6,7-dihydro-7,7-dimethyl-5-[2-(2-pyridinyl)ethenyl]benzo[b]thien-2-yl]-, hydrochloride (1:1) |
C20H19Cl2N3OS |
HR279464 |
Adamantan-1-yl(3-amino-6-(pyridin-4-yl)-4-(trifluoromethyl)thieno[2,3-b]pyridin-2-yl)methanone |
C24H22F3N3OS |
HR276771 |
Azepan-1-yl(6-hydroxy-5-nitropyridin-3-yl)methanone |
C12H15N3O4 |
HR267733 |
APA modulator T4 |
C22H23N3O3 |
HR264475 |
Allyl 3-((3-(benzyloxy)-2-(ethoxycarbonyl)-4-oxopyridin-1(4H)-yl)amino)morpholine-4-carboxylate |
C23H27N3O7 |
HR264316 |
Anabasine (hydrochloride) |
C10H15ClN2 |
HR264020 |
Azetidin-3-yl(pyridin-2-yl)methanone dihydrochloride |
C9H12Cl2N2O |
HR261698 |
AV-153 (free base) |
C14H19NO6 |
HR261515 |
AM-Imidazole-PA-Boc |
C12H22N4O2 |
HR261451 |
Ac-His-Trp-Ala-Val-Gly-His-Leu-NH2 |
C41H57N13O8 |
HR261402 |
Acetyl tetrapeptide-3 |
C22H39N9O5 |
HR259603 |
Acalabrutinib enantiomer |
C26H23N7O2 |
HR259591 |
AZD-7451 |
C18H19FN8O |